The University of Liverpool is most grateful to Cancer Research and Genetics UK and their supporters for the enormous generosity in supporting our research needs over the years. The recent donation to the Translational Immunology Group in the Department of Molecular and Clinical Cancer Medicine has supported the purchase of two vital pieces of equipment:
Evident/Olympus microscope CX43
This microscope will be used for our work in immunohistochemistry.
We have a large panel of antibodies that we are developing for use in a large multiplex panel however, they all need to be worked up individually.
We will use this microscope in conjunction with pathologists to confirm staining on control and cancer tissues prior to their use in a multiplex assay.
EVOS™ XL Core Configured Cell Imager with Mechanical Stage.
We will use this in the laboratory for cell culture.
This microscope is that it has a screen which will enable the laboratory group to jointly look at the cells and also to take images of cells.
This capability will be extremely valuable to record the visual differences in cells as we culture them under different conditions.
The Translational Immunology Group is currently working on a number of key areas of immunotherapy for cancer treatment, including head and neck cancer, lung cancer, mesothelioma, and glioblastoma, which is the most common type of primary brain cancer.
Despite intensive treatment with surgery, radiotherapy & chemotherapy, people with glioblastoma on average lose 20 years of life – the highest average years of life lost compared to other cancers.
The group are working on a new type of treatment that is revolutionising oncology by manipulating the body’s own immune system into fighting cancer.
Thank you for helping us to research promising new treatments for these devastating diseases.
For more information please contact:
Development and Alumni Relations team
University of Liverpool
T: +44 (0)151 794 6940